menu
    • menu

    Company profile for Teva Pharmaceutical Industries

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-2025-04-21

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong glob...
    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Teva Pharmaceutical IndustriesIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    5 Basel St., Petach Tikva Israel, 49131
    Telephone
    Telephone
    +972-3-9267267
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tevapharm.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/teva-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI North America

    Not Confirmed

    envelop Contact Supplier

    CPhI North America

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    This week, SpeakPharma interviews Pete Werth III, the new president of ChemWerth, a company that has been at the forefront of the generic pharmaceutical industry for over four decades. He shares his vision for ChemWerth, which includes his commitment to strengthening global manufacturing relationships, and enhancing supply chain resilience. Additionally, he highlights the key aspects of a successful drug master file (DMF). HIGHLIGHTS// Pete Werth III, the new president of ChemWerth/ vision for ChemWerth/ commitment to strengthening global manufacturing relationships/ key aspects of a successful drug master file Your father, Peter J. Werth, is recognized as one of the founders of the generic pharmaceutical industry, having built ChemWerth from the ground up over four decades ago. How do you view his legacy? As you take the helm, what key lessons or principles from his leadership do you intend to carry forward? My father, Peter J. Werth, is a true pioneer in the generic pharmaceutical industry. Over his 42‐year tenure, he not only built ChemWerth from a humble garage startup into a global leader in generic API development but also established standards that many in our industry now take for granted. Under his leadership, we filed our very first DMF in 1987 and have since achieved more than 500 DMF filings. With an average review cycle of just 0.79, we have been far outperforming the industry average of 2.5 cycles. His focus on quality, regulatory excellence, and a relentless commitment to customers’ success set the foundation for our reputation as a trusted supplier of over 500 APIs sourced from more than 30 cGMP-certified facilities worldwide. Equally inspiring is his dedication to nurture long-term, mutually beneficial relationships with manufacturing partners across the US, Europe, India, and China, as well as his passion for giving back to the community through philanthropic initiatives. As I take the helm, I intend to build on his guiding principles — sustaining our high standards of quality and compliance while pursuing innovation in regulatory strategy, diversifying our supply chain, and embracing new technologies and approaches to remain competitive in an evolving market. I will also strive to continue his legacy of mentorship, ensuring that our company culture remains rooted in integrity and diligence, with an unyielding focus on making safe, affordable medicines available worldwide. HIGHLIGHTS// trusted supplier of over 500 APIs/ 30 cGMP-certified facilities worldwide/ embracing new technologies and approaches to remain competitive What are your top priorities as the new president of ChemWerth? How do you plan to strengthen and expand relationships with manufacturers worldwide? My immediate priorities as the new president are twofold: to enhance the value we deliver to our customers and, to deepen our relationships with our manufacturing partners worldwide. We will further diversify our supply chain and broaden our product portfolio. Our expansion plans include upgrading equipment, and hiring additional highly skilled scientists, engineers, and GMP auditors. We will also leverage our proprietary product selection and regulatory submission processes. These processes help us get the regulatory filing right the first time, and allows us to be approved 44 percent faster than the industry average. This helps our customers gain a competitive edge in the market. In essence, by strengthening operational excellence and expanding our global network, we intend to continue the company’s long-standing commitment to customer success and process innovation. We plan to reinforce our long-standing relationships with our manufacturers — especially those in strategic markets like China and India — by helping our partners meet the highest standards of regulatory compliance and current good manufacturing practice (cGMP) quality. This balanced approach of strengthening existing partnerships while pioneering new ones is key to maintaining and growing our competitive edge. HIGHLIGHTS// diversify our supply chain and broaden our product portfolio/ commitment to customer success and process innovation/ filings approved 44 percent faster than the industry average When ChemWerth last spoke to PharmaCompass, there was a mention of investing millions of dollars in expanding manufacturing partnerships in China and India. Can you elaborate on the success of these partnerships, and how have they contributed to ChemWerth’s overall growth? Our strategic, multimillion-dollar investments in manufacturing partnerships are a cornerstone of our growth strategy. Over the past few years, these joint ventures have proven their worth by diversifying our supply base and mitigating the risk of global supply chain disruptions — a lesson that became all too clear during the Covid-19 pandemic. These investments are already paying dividends. They help us support manufacturers producing steroids, hormones, veterinary products, and large-volume APIs, while also accelerating the development of small-molecule inhibitors and new generic APIs. We have ensured that our partners are equipped with the latest equipment and trained personnel to meet cGMP standards. By partnering with facilities in these markets, we now have access to state-of-the-art production capabilities that enable us to produce a wider range of APIs at competitive costs. The success of these partnerships is evident in our ability to consistently file DMFs rapidly — often on the first cycle — and deliver affordable, high-quality medicines to patients worldwide. This supports our clients’ growth trajectory and has helped us expand into new markets. This strategy has reinforced our global footprint — supporting our presence in 38 countries with over 100 products — and positioned us well to capitalize on a global generic drug market projected to grow at a compounded annual growth rate of 5.4 percent from 2022 to 2030, to reach a size of US$ 671 billion by 2030. HIGHLIGHTS// strategic multimillion-dollar investments/ support manufacturers producing steroid, hormone, veterinary products/ development of small-molecule inhibitors and new generic APIs/ ensured partners are equipped with the latest equipment and trained personnel ChemWerth has an impressive track record, and an over 40-year relationship with the US Food and Drug Administration (FDA). What are the key aspects of a successful DMF? Are there specific challenges manufacturers face in preparing DMFs, and how does ChemWerth help them overcome these hurdles? ChemWerth’s record of filing over 500 DMFs in 38 countries reflects our commitment to excellence in regulatory compliance and quality management. A successful DMF is built on comprehensive documentation that rigorously follows cGMP guidelines, robust analytical validation, and detailed tracking of every step. Every DMF we file meticulously details the entire manufacturing process — from raw material acquisition to final batch production. This comprehensive approach ensures that our submissions meet the rigorous quality, safety, and efficacy standards expected by the FDA. Our team stays continuously updated on the evolving guidelines and protocols, which allows us to file DMFs that align with current FDA practices. We recognize that many manufacturers face challenges such as complex regulatory requirements, lengthy review cycles, and the need for precise coordination between various production stages. ChemWerth helps them overcome these hurdles by offering end-to-end regulatory support, detailed internal audits, and continuous training on cGMP and FDA requirements. Our efficiency is a critical competitive advantage. By receiving approvals 44 percent faster than the industry average, we help our customers get their products to market faster, resulting in larger market share and increased profits. HIGHLIGHTS// over 500 DMFs in 38 countries/ robust analytical validation/ end-to-end regulatory support What is your vision for ChemWerth over the next few years? How do you plan to navigate the challenges and opportunities in the generic pharmaceutical industry? I plan to continue to add value for our customers, and look for innovative ways to compete in today’s generic pharmaceutical landscape. At ChemWerth, our vision for the future is rooted in both our proud legacy and our relentless drive for innovation. We will further diversify our supply chain and expand our product portfolio. We have begun leveraging our expertise to supply APIs for biosimilars and new drug applications (NDAs), while maintaining our reputation for rapid regulatory approvals. With unwavering determination, we uphold our “First to Quality. Fast to Market.” approach — delivering high-quality APIs to customers worldwide while leveraging our expertise to give them a competitive edge in their markets. HIGHLIGHTS// supply APIs for biosimilars and NDAs/ give customers a competitive edge in their markets 

    Impressions: 958

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage

    Radio Compass
    12 Mar 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

    Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

    In 2024, Big Pharma players consolidated and maintained their dominance, even as innovation continued to reshape the pharmaceutical landscape. The primary change last year was the meteoric rise of glucagon-like peptide-1 (GLP-1) receptor agonists that treat diabetes and help in weight loss.Amongst drugmakers, Pfizer retained its numero uno spot with an impressive US$ 63.6 billion in prescription drug sales (up 7 percent from US$ 59.56 billion reported in 2023), despite ever-shrinking Comirnaty sales, which settled at US$ 5.35 billion in 2024 (from US$ 11.22 billion in 2023).Merck secured the second position with revenues of US$ 57.4 billion, a growth of 7 percent over 2023. This performance was predominantly fueled by Keytruda, which now accounts for more than half of Merck’s total pharmaceutical revenue. Johnson & Johnson came a close third with US$ 57 billion in prescription drug sales (up from US$ 54.76 billion in 2023).AbbVie held the fourth position with US$ 56.33 billion in sales, achieving 3.7 percent growth despite the ongoing erosion of Humira revenue. This flagship immunology drug saw sales plummet 37.6 percent to approximately US$ 9 billion, a US$ 5.4 billion reduction compared to 2023. Humira’s loss was offset by AbbVie’s newer immunology assets, particularly Skyrizi and Rinvoq, both of which demonstrated exceptional growth trajectories. View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available)European giants Astra, Roche, Novartis, Sanofi round out top 10 list; Novo, Lilly see astounding growthWhile the top four positions were dominated by American drugmakers, European giants dominated the lower half of the top 10 list.AstraZeneca secured the fifth spot with US$ 54.1 billion in sales, thereby posting impressive growth of 18.1 percent over 2023. Roche claimed the sixth position with US$ 50.9 billion in sales while Novartis ranked seventh — with sales of US$ 50.3 billion. Novartis' impressive 10.8 percent sales growth is attributed to its innovative medicines portfolio. Oncology therapies remained a cornerstone for both these Swiss drugmakers.Bristol Myers Squibb (BMS) secured eighth position with revenues of US$ 48.3 billion, representing 7.3 percent growth over the previous year. At US$ 45 billion, Eli Lilly posted 32 percent revenue growth last year. Its GLP-1 drug Mounjaro helped Lilly move up from the tenth in 2023 to the ninth spot last year.Sanofi landed the tenth position with US$ 42.6 billion in sales, propelled largely by the expanding indications of Dupixent. The French multinational has increasingly focused on this immunology blockbuster, while also garnering more sales from its vaccine and rare disease portfolios.Novo Nordisk merits a mention as it posted an incredible 26 percent year-on-year growth. It retained its eleventh spot with US$ 40.25 billion in sales. Novo’s growth was driven almost exclusively by the extraordinary success of its GLP-1 receptor agonist portfolio. View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available)       Merck’s Keytruda retains throne with US$ 29.5 bn in sales, as Novo’s semaglutide nips at its heelsMoving on to drugs, Merck’s Keytruda (pembrolizumab) solidified its position as the world’s top-selling pharmaceutical product with sales exceeding US$ 29.5 billion and year-on-year growth of 17.88 percent (US$ 4.5 billion). This remarkable performance was driven by steady sales growth across more than 40 indications in the US. In 2024 alone, Keytruda secured four new approvals from the US Food and Drug Administration (FDA).However, Novo Nordisk’s semaglutide sales (Ozempic, Wegovy and Rybelsus) gave Keytruda a run for its money. Across the three blockbuster drugs, semaglutide earned the Danish drugmaker around US$ 28 billion — i.e. a year-on-year increase of 38 percent.Novo’s Ozempic (semaglutide) reached over US$ 16.7 billion in sales — a 20 percent increase from 2023. Originally approved in 2017 to improve glycemic control, Ozempic bagged additional approvals in 2020, and in January 2025. It is now approved to reduce the risk of major cardiovascular events, as well as to reduce cardiovascular risk and to lower the likelihood of chronic kidney disease in type 2 diabetes patients.Sales of Wegovy (semaglutide), the other blockbuster GLP-1 drug from Novo, grew by a whopping 85.7 percent to over US$ 8 billion.Sanofi and Regeneron’s Dupixent (dupilumab) secured the number three spot with sales of US$ 13.6 billion, representing an impressive 17.2 percent year-on-year growth. In 2024, Dupixent received three new approvals and one label update. Notably, it became the first-ever biologic medicine approved for patients with chronic obstructive pulmonary disease (COPD). View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available) AbbVie’s post-Humira strategy pays off as Skyrizi surges 51%; Lilly’s Mounjaro posts 124% growthGilead Sciences’ HIV treatment Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) showed robust growth of 13.27 percent, touching sales of US$ 13.42 billion in 2024 and emerging as the fourth largest selling drug. Biktarvy now commands over 50 percent of the US HIV treatment market. Unlike many other drugs on this list, Biktarvy faces no immediate patent challenges, with key protections expected to remain intact until 2033.BMS and Pfizer’s anticoagulant Eliquis (apixaban) claimed the fifth position with US$ 13.33 billion in sales, representing a 9.21 percent year-on-year increase. AbbVie’s Skyrizi (risankizumab) emerged as one of the fastest-growing assets with a 50.95 percent year-on-year increase, generating US$ 11.71 billion in 2024 sales, thereby surpassing Humira’s (adalimumab) diminished sales.This impressive performance, combined with Rinvoq’s (upadacitinib) growth, has prompted  AbbVie to raise its long-term outlook for these products. The company now expects combined Skyrizi and Rinvoq revenues to exceed US$ 31 billion by 2027, with Skyrizi alone projected to generate over US$ 20 billion.Johnson & Johnson’s Darzalex (daratumumab) claimed the seventh position with US$ 11.67 billion in sales, representing 19.77 percent growth over 2023.Lilly’s Mounjaro (tirzepatide) demonstrated dramatic growth with sales increasing 123.51 percent to US$ 11.54 billion. This performance was complemented by Zepbound (tirzepatide, for weight loss), which contributed US$ 4.9 billion to Lilly’s revenue. By the end of 2024, Mounjaro received FDA approval for a new indication in obstructive sleep apnea (OSA), becoming the first and only prescription medicine for moderate-to-severe OSA in adults with obesity.Stelara (ustekinumab) ranked ninth, bringing J&J sales of US$ 10.36 billion, showing a modest decline of 4.91 percent from its 2023 sales.Vertex’s triple-combination therapy Trikafta (elexacaftor/tezacaftor/ivacaftor) for treating cystic fibrosis rounded out the top ten list with sales of US$ 10.2 billion, up 14 percent from the previous year. View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available) Our viewIn 2024, transformative therapies like GLP-1 receptor agonists drove growth in the pharmaceutical industry. This year, we expect GLP-1 drugs to dethrone Keytruda from the number one spot. Along with novel immunology agents, we expect GLP-1 drugs to realign the pharmaceutical market.  
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 3004

    https://www.pharmacompass.com/radio-compass-blog/top-pharma-companies-drugs-in-2024-merck-s-keytruda-maintains-top-spot-as-novo-s-semaglutide-nips-at-its-heels

    #PharmaFlow by PHARMACOMPASS
    24 Apr 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    US Court rules in favor of FDA, Salix, Teva, against Norwich
    US Court rules in favor of FDA, Salix, Teva, against Norwich

    17 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/us-district-court-grants-summary-judgment-in-favor-of-fda-salix-and-t-1016430

    ACCESSWIRE
    17 Apr 2025
    Share Share
    Actavis to Slash 200 Workers as Teva’s Consolidation Efforts
    Actavis to Slash 200 Workers as Teva’s Consolidation Efforts

    08 Apr 2025

    // BIOSPACE

    https://www.biospace.com/actavis-to-slash-200-workers-as-part-of-teva-s-consolidation-efforts

    BIOSPACE
    08 Apr 2025
    Share Share
    Teva and Samsung Bioepis Launch EPYSQLI in the U.S.
    Teva and Samsung Bioepis Launch EPYSQLI in the U.S.

    07 Apr 2025

    // PRESS RELEASE

    https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2025/Teva-and-Samsung-Bioepis-Announce-Biosimilar-EPYSQLI-eculizumab-aagh-InjectionNow-Available-in-the-United-States/default.aspx

    PRESS RELEASE
    07 Apr 2025
    Share Share
    Teva's Ajovy FDA filing accepted for pediatric migraine prevention
    Teva's Ajovy FDA filing accepted for pediatric migraine prevention

    07 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/07/3056596/0/en/Teva-Announces-FDA-Filing-Acceptance-for-AJOVY-fremanezumab-in-Pediatric-Episodic-Migraine-Prevention.html

    GLOBENEWSWIRE
    07 Apr 2025
    Share Share
    Teva's Schizophrenia Portfolio Enhanced by Ph 3 Trial Results
    Teva's Schizophrenia Portfolio Enhanced by Ph 3 Trial Results

    31 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/31/3052605/0/en/New-Data-Strengthens-Teva-s-Schizophrenia-Portfolio-Including-Phase-3-SOLARIS-Trial-Survey-Results-Demonstrating-Patient-and-Healthcare-Professional-Satisfaction-with-TEV-749-olanz.html

    GLOBENEWSWIRE
    31 Mar 2025
    Share Share
    Teva Releases Q1 2025 Aide Memoire
    Teva Releases Q1 2025 Aide Memoire

    27 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/27/3051046/0/en/Teva-Releases-Q1-2025-Aide-Memoire.html

    GLOBENEWSWIRE
    27 Mar 2025
    Share Share

    USDMF

    read-more
    read-more

    01

    5-fluorouracil

    Israel
    Iran Expo
    Not Confirmed
    arrow

    02

    Abiraterone Acetate

    Israel
    Iran Expo
    Not Confirmed
    arrow

    03

    Acetazolamide

    Israel
    Iran Expo
    Not Confirmed
    arrow

    04

    Acetylsulfisoxazole

    Israel
    Iran Expo
    Not Confirmed
    arrow

    05

    Acyclovir

    Israel
    Iran Expo
    Not Confirmed
    arrow

    06

    Acyclovir Usp

    Israel
    Iran Expo
    Not Confirmed
    arrow

    07

    Acyclovir Usp

    Israel
    Iran Expo
    Not Confirmed
    arrow

    08

    Acyclovir Usp

    Israel
    Iran Expo
    Not Confirmed
    arrow

    09

    Adapalene Usp

    Israel
    Iran Expo
    Not Confirmed
    arrow

    10

    Afatinib Dimaleate

    Israel
    Iran Expo
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    LISTED APIs

    read-more
    read-more
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    abiraterone

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 empl...
    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
    blank

    01

    abiraterone

    Israel
    Iran Expo
    Not Confirmed
    arrow

    abiraterone

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Pharmaceutical Industries

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.

    About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a ye...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Acyclovir

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 empl...
    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
    blank

    02

    Acyclovir

    Israel
    Iran Expo
    Not Confirmed
    arrow

    Acyclovir

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Pharmaceutical Industries

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.

    About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a ye...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Afatinib Dimaleate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 empl...
    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
    blank

    03

    Afatinib Dimaleate

    Israel
    Iran Expo
    Not Confirmed
    arrow

    Afatinib Dimaleate

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Pharmaceutical Industries

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.

    About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a ye...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Alclometasone Dipropionate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 empl...
    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
    blank

    04

    Alclometasone Dipropionate

    Israel
    Iran Expo
    Not Confirmed
    arrow

    Alclometasone Dipropionate

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Pharmaceutical Industries

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.

    About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a ye...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Alendronate Sodium

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 empl...
    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
    blank

    05

    Alendronate Sodium

    Israel
    Iran Expo
    Not Confirmed
    arrow

    Alendronate Sodium

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Pharmaceutical Industries

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.

    About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a ye...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Allopurinol

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 empl...
    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
    blank

    06

    Allopurinol

    Israel
    Iran Expo
    Not Confirmed
    arrow

    Allopurinol

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Pharmaceutical Industries

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.

    About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a ye...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Amcinonide

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 empl...
    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
    blank

    07

    Amcinonide

    Israel
    Iran Expo
    Not Confirmed
    arrow

    Amcinonide

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Pharmaceutical Industries

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.

    About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a ye...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Amitriptyline

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 empl...
    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
    blank

    08

    Amitriptyline

    Israel
    Iran Expo
    Not Confirmed
    arrow

    Amitriptyline

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Pharmaceutical Industries

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.

    About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a ye...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Amlodipine Besylate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 empl...
    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
    blank

    09

    Amlodipine Besylate

    Israel
    Iran Expo
    Not Confirmed
    arrow

    Amlodipine Besylate

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Pharmaceutical Industries

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.

    About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a ye...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Anastrozole

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 empl...
    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
    blank

    10

    Anastrozole

    Israel
    Iran Expo
    Not Confirmed
    arrow

    Anastrozole

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Pharmaceutical Industries

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.

    About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a ye...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva’s AJOVY Accepted By FDA For Pediatric Migraine Prevention

    Details:

    Ajovy (fremanezumab) a FDA approved, humanized mAb which selectively binds the calcitonin gene-related peptide (CGRP). It is being investigated for the prevention of migraine in 6-17 years patients.


    Lead Product(s): Fremanezumab

    Therapeutic Area: Neurology Brand Name: Ajovy

    Study Phase: Phase IIIProduct Type: Antibody

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable April 07, 2025

    blank

    01

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Fremanezumab

    Therapeutic Area : Neurology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Teva’s AJOVY Accepted By FDA For Pediatric Migraine Prevention

    Details : Ajovy (fremanezumab) a FDA approved, humanized mAb which selectively binds the calcitonin gene-related peptide (CGRP). It is being investigated for the prevention of migraine in 6-17 years patients.

    Product Name : Ajovy

    Product Type : Antibody

    Upfront Cash : Inapplicable

    April 07, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva and Samsung Bioepis Launch EPYSQLI in the U.S.

    Details:

    Epysqli (eculizumab) is a complement C5 inhibitor antibody which is indicated to treat paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.


    Lead Product(s): Eculizumab

    Therapeutic Area: Rare Diseases and Disorders Brand Name: Epysqli

    Study Phase: Approved FDFProduct Type: Antibody

    Recipient: Samsung Bioepis

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable April 07, 2025

    blank

    02

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Eculizumab

    Therapeutic Area : Rare Diseases and Disorders

    Highest Development Status : Approved FDF

    Recipient : Samsung Bioepis

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Teva and Samsung Bioepis Launch EPYSQLI in the U.S.

    Details : Epysqli (eculizumab) is a complement C5 inhibitor antibody which is indicated to treat paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.

    Product Name : Epysqli

    Product Type : Antibody

    Upfront Cash : Inapplicable

    April 07, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Highlights Positive Schizophrenia Data From SOLARIS Trial

    Details:

    TEV-'749 is an investigational once-monthly subcutaneous LAI of the 2nd generation antipsychotic olanzapine being developed in in adult patients diagnosed with schizophrenia.


    Lead Product(s): Olanzapine

    Therapeutic Area: Psychiatry/Psychology Brand Name: TEV-‘749

    Study Phase: Phase IIIProduct Type: Other Small Molecule

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable March 31, 2025

    blank

    03

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Olanzapine

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Teva Highlights Positive Schizophrenia Data From SOLARIS Trial

    Details : TEV-'749 is an investigational once-monthly subcutaneous LAI of the 2nd generation antipsychotic olanzapine being developed in in adult patients diagnosed with schizophrenia.

    Product Name : TEV-‘749

    Product Type : Other Small Molecule

    Upfront Cash : Inapplicable

    March 31, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva, Medincell Get FDA Acceptance for UZEDY in Bipolar I Disorder

    Details:

    Uzedy (risperidone) is an extended-release 5HT2a/D2 receptor Inhibitor injectable suspension, being investigated for the maintenance treatment of BP-I in adults.


    Lead Product(s): Risperidone

    Therapeutic Area: Psychiatry/Psychology Brand Name: Uzedy

    Study Phase: Phase IIIProduct Type: Other Small Molecule

    Sponsor: MedinCell

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable February 25, 2025

    blank

    04

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Risperidone

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : MedinCell

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Teva, Medincell Get FDA Acceptance for UZEDY in Bipolar I Disorder

    Details : Uzedy (risperidone) is an extended-release 5HT2a/D2 receptor Inhibitor injectable suspension, being investigated for the maintenance treatment of BP-I in adults.

    Product Name : Uzedy

    Product Type : Other Small Molecule

    Upfront Cash : Inapplicable

    February 25, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Completes Pivotal Phase 3 Olanzapine LAI Trial in Schizophrenia

    Details:

    TEV-'749 (olanzapine) is a novel D2/5-HT2 receptor inhibitor which is under phase 3 clinical development for the treatment of patients with Schizophrenia.


    Lead Product(s): Olanzapine

    Therapeutic Area: Psychiatry/Psychology Brand Name: TEV-'749

    Study Phase: Phase IIIProduct Type: Other Small Molecule

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable February 10, 2025

    blank

    05

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Olanzapine

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Teva Completes Pivotal Phase 3 Olanzapine LAI Trial in Schizophrenia

    Details : TEV-'749 (olanzapine) is a novel D2/5-HT2 receptor inhibitor which is under phase 3 clinical development for the treatment of patients with Schizophrenia.

    Product Name : TEV-'749

    Product Type : Other Small Molecule

    Upfront Cash : Inapplicable

    February 10, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Apotex Acquires US rights to PROVIGIL® (modafinil) and NUVIGIL® (armodafinil)

    Details:

    Acquiring the US rights to PROVIGIL (modafinil) and NUVIGIL (armodafinil) indicated to improve wakefulness in adult patients marks a strategic milestone for Apotex.


    Lead Product(s): Modafinil

    Therapeutic Area: Sleep Brand Name: Provigil

    Study Phase: Approved FDFProduct Type: Other Small Molecule

    Sponsor: Apotex Inc

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Acquisition January 09, 2025

    blank

    06

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Modafinil

    Therapeutic Area : Sleep

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Apotex Inc

    Deal Size : Undisclosed

    Deal Type : Acquisition

    DEALS_DEV arrow-down

    Apotex Acquires US rights to PROVIGIL® (modafinil) and NUVIGIL® (armodafinil)

    Details : Acquiring the US rights to PROVIGIL (modafinil) and NUVIGIL (armodafinil) indicated to improve wakefulness in adult patients marks a strategic milestone for Apotex.

    Product Name : Provigil

    Product Type : Other Small Molecule

    Upfront Cash : Undisclosed

    January 09, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Neuraxpharm Acquires Provigil®, Nuvigil® to Expand Branded Business

    Details:

    Neuraxpharm has acquired these products Provigil (modafinil) and Nuvigil (armodafinil), both of which are indicated for the treatment of EDS in adults with narcolepsy.


    Lead Product(s): Modafinil

    Therapeutic Area: Sleep Brand Name: Provigil

    Study Phase: Approved FDFProduct Type: Other Small Molecule

    Sponsor: Neuraxpharm

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Acquisition January 07, 2025

    blank

    07

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Modafinil

    Therapeutic Area : Sleep

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Neuraxpharm

    Deal Size : Undisclosed

    Deal Type : Acquisition

    DEALS_DEV arrow-down

    Neuraxpharm Acquires Provigil®, Nuvigil® to Expand Branded Business

    Details : Neuraxpharm has acquired these products Provigil (modafinil) and Nuvigil (armodafinil), both of which are indicated for the treatment of EDS in adults with narcolepsy.

    Product Name : Provigil

    Product Type : Other Small Molecule

    Upfront Cash : Undisclosed

    January 07, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Eton Pharmaceuticals Advances its Commitment to Rare Disease with Acquisition of Galzin

    Details:

    Through the acquisition, Eton will add additional commercial and strategic rare disease products such as Galzin (zinc acetate), which is an FDA-approved product for the treatment of Wilson's Disease.


    Lead Product(s): Zinc Acetate Dihydrate

    Therapeutic Area: Genetic Disease Brand Name: Galzin

    Study Phase: Approved FDFProduct Type: Other Small Molecule

    Sponsor: Eton Pharmaceuticals

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Acquisition January 03, 2025

    blank

    08

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Zinc Acetate Dihydrate

    Therapeutic Area : Genetic Disease

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Eton Pharmaceuticals

    Deal Size : Undisclosed

    Deal Type : Acquisition

    DEALS_DEV arrow-down

    Eton Pharmaceuticals Advances its Commitment to Rare Disease with Acquisition of Galzin

    Details : Through the acquisition, Eton will add additional commercial and strategic rare disease products such as Galzin (zinc acetate), which is an FDA-approved product for the treatment of Wilson's Disease.

    Product Name : Galzin

    Product Type : Other Small Molecule

    Upfront Cash : Undisclosed

    January 03, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Duvakitug Phase 2b Results Show Best-in-Class Potential in Ulcerative Colitis, Crohn’s

    Details:

    TEV-’574 (duvakitug) is a potential best-in-class human IgG1-lambda 2 mAb that targets tumor necrosis factor (TNF)-like ligand 1A, also known as TNF superfamily member 15 (TNFSF15).


    Lead Product(s): Duvakitug

    Therapeutic Area: Immunology Brand Name: TEV-48574

    Study Phase: Phase IIProduct Type: Other Large Molecule

    Sponsor: Sanofi

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable December 17, 2024

    blank

    09

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Duvakitug

    Therapeutic Area : Immunology

    Highest Development Status : Phase II

    Partner/Sponsor/Collaborator : Sanofi

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Duvakitug Phase 2b Results Show Best-in-Class Potential in Ulcerative Colitis, Crohn’s

    Details : TEV-’574 (duvakitug) is a potential best-in-class human IgG1-lambda 2 mAb that targets tumor necrosis factor (TNF)-like ligand 1A, also known as TNF superfamily member 15 (TNFSF15).

    Product Name : TEV-48574

    Product Type : Other Large Molecule

    Upfront Cash : Inapplicable

    December 17, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Confirms AJOVY® Efficacy for Migraine Prevention from China Study

    Details:

    Ajovy is a FDA approved, humanized mAb which selectively binds the calcitonin gene-related peptide (CGRP). It is being investigated for the prevention of migraine in adult Chinese patients.


    Lead Product(s): Fremanezumab

    Therapeutic Area: Neurology Brand Name: Ajovy

    Study Phase: Approved FDFProduct Type: Antibody

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable November 04, 2024

    blank

    10

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    Iran Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Fremanezumab

    Therapeutic Area : Neurology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Teva Confirms AJOVY® Efficacy for Migraine Prevention from China Study

    Details : Ajovy is a FDA approved, humanized mAb which selectively binds the calcitonin gene-related peptide (CGRP). It is being investigated for the prevention of migraine in adult Chinese patients.

    Product Name : Ajovy

    Product Type : Antibody

    Upfront Cash : Inapplicable

    November 04, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED and get a quotation

    RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED is a supplier offers 334 products (APIs, Excipients or Intermediates).

    Find a price of Allopurinol bulk with DMF, CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Amoxicillin Trihydrate bulk with DMF, CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Atorvastatin bulk with DMF, CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Galantamine Hydrobromide bulk with CEP, JDMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Nomegestrol Acetate bulk with DMF, CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Salbutamol Sulphate bulk with DMF, CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Amlodipine Besylate bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Valsartan bulk with JDMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Abiraterone Acetate bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Aciclovir bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Afatinib bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Alclometasone Dipropionate bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Alendronate Sodium bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Allopurinol bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Amcinonide bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Amitriptyline Hydrochloride bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Anastrozole bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Apixaban bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Aripiprazole bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Armodafinil bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Atenolol bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Atomoxetin Hydrochloride bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Betamethasone Dipropionate bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Bleomycin Sulphate bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Calcitriol bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Capecitabine bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Carbamazepine bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Carvedilol bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Clarithromycin bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Clascoterone bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Co-Dergocrine Mesilate bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Desmopressin Acetate bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Dorzolamide Hydrochloride bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Doxepin Hydrochloride bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Drospirenone bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Elagolix Sodium bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Eltrombopag bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Epirubicin Hydrochloride bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fedratinib bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fluorouracil bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fluticasone Furoate bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Formoterol Fumarate bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Furosemide bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Gabapentin bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Gemcitabine bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Gemfibrozil bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Glycerol Phenylbutyrate bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ivosidenib bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Loperamide Hydrochloride bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Lovastatin bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Memantine Hydrochloride bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Methyldopa bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Metoprolol Succinate bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Metoprolol Tartrate bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Midostaurin bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Migalastat bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Milk Thistle Extract bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Mirtazapine bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Mycophenolate Mofetil bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Naproxen Sodium bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Neratinib bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Nifedipine bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Nilotinib bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Nintedanib Esylate bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Nomegestrol Acetate bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ondansetron Hydrochloride bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Paclitaxel bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Pancuronium Bromide bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Pantoprazole Sodium bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Probenecid bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Quetiapine Hemifumarate bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Remimazolam Besylate bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ribociclib bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Rimegepant Sulfate bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Risdiplam bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Risperidone bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Samidorphan bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Saxagliptin Hydrochloride bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Silybum Marianum L. bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Simvastatin bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Tafamidis bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Tamoxifen Citrate bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ticlopidine bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Tigecycline bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Triamcinolone Acetonide bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Triheptanoin bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Trilaciclib bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Tucatinib bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Valacyclovir Hydrochloride bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Valbenazine Tosylate bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Valsartan bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Vancomycin Hydrochloride bulk with JDMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Voclosporin bulk with DMF offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Olanzapine, Form II Micronised bulk with CEP offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Acetazolamide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Aciclovir bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Adapalene bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Amlodipine Besylate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Amoxicillin Sodium bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ampicillin Trihydrate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Armodafinil bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Diclofenac Sodium bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ergotamine Tartrate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Sulfisoxazole bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Trimethoprim bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Water bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ziprasidone Hydrochloride bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Amitriptyline bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Anidulafungin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Apremilast bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Aripiprazole bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Atosiban bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Atracurium Besylate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Azacitidine bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Azithromycin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Aztreonam bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Beclomethasone Dipropionate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Betamethasone bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Betamethasone Acetate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Betamethasone Valerate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Bicalutamide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Bimatoprost bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Bivalirudin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Bortezomib bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Bromocriptine Mesylate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Budesonide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Buprenorphine bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Buprenorphine Hydrochloride bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Butorphanol Tartrate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Cabazitaxel bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Cabergoline bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Calcipotriol bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Candesartan Cilexetil bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Carbidopa bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Carboplatin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Carfilzomib bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Carvedilol Phosphate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of CAS 103639-04-9 bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Caspofungin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ceritinib bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Chlormadinone Acetate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Cilostazol bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Cinacalcet Hydrochloride bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Cisatracurium Besylate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Cisplatin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Clobetasol Propionate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Clomiphene Citrate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Clonazepam bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Clopidogrel bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Cyclosporine bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Cyproterone Acetate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Dabigatran Etexilate Mesylate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Darifenacin Hydrobromide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Dasatinib bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Daunorubicin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Deferasirox bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Deferoxamine Mesylate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Desloratadine bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Desonide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Desvenlafaxine Fumarate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Desvenlafaxine Succinate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Dexamethasone bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Diflorasone bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Difluprednate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Dihydroergocristine bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Dihydroergocryptine bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Dihydroergotamine Mesylate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Dihydroergotoxine Mesylate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Diltiazem bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Dimethyl Fumarate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Disodium Pamidronate Pentahydrate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Docetaxel bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Dolutegravir Sodium bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Donepezil bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Doxcercalciferol bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Doxepin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Doxorubicin Hydrochloride bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Duloxetine Hydrochloride bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Edoxaban Tosylate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Eletriptan Hydrobromide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Elocalcitol bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Empagliflozin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Eptifibatide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ergonovine Maleate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Erlotinib bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Eszopiclone bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Etilevodopa bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Etodolac bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Etoposide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Exenatide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ezetimibe bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Famciclovir bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Febuxostat bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fidaxomicin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fingolimod Hydrochloride bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fludarabine Phosphate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fludrocortisone Acetate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Flunisolide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fluocinolone Acetonide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fluocinonide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fluorometholone bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fluorometholone Acetate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fluoxetine Hydrochloride bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fluticasone Propionate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fluvastatin Sodium bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fluvoxamine bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Fulvestrant bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Haloperidol bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Haloperidol Decanoate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Hydrochlorothiazide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ibandronate Sodium bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ibrutinib bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Icatibant Acetate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Idarubicin Hydrochloride bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Imatinib Mesylate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Imipramine bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Imiquimod bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ingenol Mebutate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Irbesartan bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Irinotecan Hydrochloride bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Lamotrigine bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Lansoprazole bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of LAROPIPRANT bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Latanoprost bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ledipasvir bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Leflunomide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Letrozole bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Leuprolide Acetate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Levalbuterol Sulfate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Levetiracetam bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Levofloxacin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Linaclotide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Linagliptin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Linezolid bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Liraglutide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Lixisenatide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Losartan Potassium bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Lovastatin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Lurasidone Hydrochloride bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Macitentan bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Maxacalcitol bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Medroxyprogesterone Acetate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Megestrol Acetate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Methylergonovine Maleate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Methylprednisolone Hemisuccinate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Methylprednisolone Sodium Succinate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Metopimazine bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Milk Thistle Extract bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Mitomycin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Mometasone Furoate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Montelukast Sodium bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Mupirocin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Mupirocin Calcium bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Mycophenolate Sodium bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Naproxen bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Nateglinide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Nefazodone bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Nicergoline bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Norgestimate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Obeticholic Acid bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Octreotide Acetate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Olanzapine bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Olmesartan Medoxomil bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Omeprazole bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ondansetron bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Oxaliplatin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ozanimod bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Paliperidone bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Paliperidone Palmitate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Palonosetron bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Paricalcitol bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Paroxetine Hydrochloride bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Pemetrexed bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Pemetrexed Disodium bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Pentoxifylline bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Perampanel bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Percorten bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Pergolide Mesylate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Pioglitazone bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Pralatrexate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Pramlintide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Pravastatin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Pregabalin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Raloxifene Hydrochloride bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Raltegravir Potassium bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ramelteon bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Regorafenib bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Rilpivirine bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Risedronate Sodium bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Rivaroxaban bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Rocuronium Bromide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Rolapitant HCl bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Romidepsin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Rosuvastatin Calcium bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Rotigotine bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Sapropterin Hydrochloride bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Saxagliptin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Selexipag bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Sildenafil Citrate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Silver Sulfadiazine bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Silymarin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Sitagliptin Phosphate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Sofosbuvir bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Sorafenib bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Succinate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Sugammadex Sodium bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Sunitinib bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Tacrolimus bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Tadalafil bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Telmisartan bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Terguride bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Teriparatide Acetate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ticagrelor bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Timolol Maleate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Tiotropium Bromide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Tobramycin bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Tolterodine Tartrate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Torsemide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Travoprost bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Trazodone Hydrochloride bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Triamcinolone bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Triptorelin Pamoate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Ulipristal Acetate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Umeclidinium Bromide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Vecuronium Bromide bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Venlafaxine bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Vilanterol Trifenatate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Vilazodone bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Warfarin Sodium bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Zaleplon bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Zavegepant HCl bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Zoledronic Acid bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Zolmitriptan bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Find a price of Zolpidem Tartrate bulk offered by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search